Stereotactic Ablative Radiotherapy for Oligometastatic Disease: Great Enthusiasm but Scant Evidence
The prospective study Pulmonary Metastasectomy in Colorectal Cancer (N = 391) showed that expert selection was made on known prognostic features – number of metastases, tumour markers, liver involvement, interval – and patient performance and outcomes replicated follow-up studies. In the nested cont...
Gespeichert in:
Veröffentlicht in: | Clinical oncology (Royal College of Radiologists (Great Britain)) 2022-05, Vol.34 (5), p.313-317 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 317 |
---|---|
container_issue | 5 |
container_start_page | 313 |
container_title | Clinical oncology (Royal College of Radiologists (Great Britain)) |
container_volume | 34 |
creator | Macbeth, F. Treasure, T. |
description | The prospective study Pulmonary Metastasectomy in Colorectal Cancer (N = 391) showed that expert selection was made on known prognostic features – number of metastases, tumour markers, liver involvement, interval – and patient performance and outcomes replicated follow-up studies. In the nested controlled trial all factors were well balanced and no survival difference remained. |
doi_str_mv | 10.1016/j.clon.2022.02.008 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2635239254</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0936655522000917</els_id><sourcerecordid>2635239254</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-e12f6269420022e10d7fd5be5d19733fd32f053b71201d8c0c9358ceb1c752b23</originalsourceid><addsrcrecordid>eNp9kFFr2zAQx8XoWLN2X6APw497cXo6RY49-hLaLC0UCmv3LGTp3CrYVirJgX772iTdY-Hg4Pjdn7sfYxcc5hx4cbmdm9b3cwTEOYwF5Rc24wshcqxKfsJmUIkiL6SUp-x7jFsAwLKsvrFTIVFggXLGzGOiQD5pk5zJVnWrk9tT9ldb59MLBb17yxofsofWPfuOko5JT-SNi6Qj_c42gXTK1n16GaLTscvqIWWPRvfjcO8s9YbO2ddGt5F-HPsZ-_dn_XR9m98_bO6uV_e5WQCknDg2BRbVAsc7kTjYZWNlTdLyailEYwU2IEW95AjclgZMJWRpqOZmKbFGccZ-HXJ3wb8OFJPqXDTUtronP0SFxfR3hXIxonhATfAxBmrULrhOhzfFQU1y1VZNctUkV8FYUI5LP4_5Q92R_b_yYXMErg4AjV_uHQUVjZsMWBfIJGW9-yz_HfuSizM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2635239254</pqid></control><display><type>article</type><title>Stereotactic Ablative Radiotherapy for Oligometastatic Disease: Great Enthusiasm but Scant Evidence</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Macbeth, F. ; Treasure, T.</creator><creatorcontrib>Macbeth, F. ; Treasure, T.</creatorcontrib><description>The prospective study Pulmonary Metastasectomy in Colorectal Cancer (N = 391) showed that expert selection was made on known prognostic features – number of metastases, tumour markers, liver involvement, interval – and patient performance and outcomes replicated follow-up studies. In the nested controlled trial all factors were well balanced and no survival difference remained.</description><identifier>ISSN: 0936-6555</identifier><identifier>EISSN: 1433-2981</identifier><identifier>DOI: 10.1016/j.clon.2022.02.008</identifier><identifier>PMID: 35232625</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Follow-Up Studies ; Humans ; Lung metastases ; Lung Neoplasms - radiotherapy ; Lung Neoplasms - surgery ; Metastasectomy ; Metastases ; Prognosis ; Prospective Studies ; Radiosurgery ; Stereotactic radiotherapy</subject><ispartof>Clinical oncology (Royal College of Radiologists (Great Britain)), 2022-05, Vol.34 (5), p.313-317</ispartof><rights>2022 The Royal College of Radiologists</rights><rights>Copyright © 2022 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-e12f6269420022e10d7fd5be5d19733fd32f053b71201d8c0c9358ceb1c752b23</citedby><cites>FETCH-LOGICAL-c400t-e12f6269420022e10d7fd5be5d19733fd32f053b71201d8c0c9358ceb1c752b23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.clon.2022.02.008$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3541,27915,27916,45986</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35232625$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Macbeth, F.</creatorcontrib><creatorcontrib>Treasure, T.</creatorcontrib><title>Stereotactic Ablative Radiotherapy for Oligometastatic Disease: Great Enthusiasm but Scant Evidence</title><title>Clinical oncology (Royal College of Radiologists (Great Britain))</title><addtitle>Clin Oncol (R Coll Radiol)</addtitle><description>The prospective study Pulmonary Metastasectomy in Colorectal Cancer (N = 391) showed that expert selection was made on known prognostic features – number of metastases, tumour markers, liver involvement, interval – and patient performance and outcomes replicated follow-up studies. In the nested controlled trial all factors were well balanced and no survival difference remained.</description><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Lung metastases</subject><subject>Lung Neoplasms - radiotherapy</subject><subject>Lung Neoplasms - surgery</subject><subject>Metastasectomy</subject><subject>Metastases</subject><subject>Prognosis</subject><subject>Prospective Studies</subject><subject>Radiosurgery</subject><subject>Stereotactic radiotherapy</subject><issn>0936-6555</issn><issn>1433-2981</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kFFr2zAQx8XoWLN2X6APw497cXo6RY49-hLaLC0UCmv3LGTp3CrYVirJgX772iTdY-Hg4Pjdn7sfYxcc5hx4cbmdm9b3cwTEOYwF5Rc24wshcqxKfsJmUIkiL6SUp-x7jFsAwLKsvrFTIVFggXLGzGOiQD5pk5zJVnWrk9tT9ldb59MLBb17yxofsofWPfuOko5JT-SNi6Qj_c42gXTK1n16GaLTscvqIWWPRvfjcO8s9YbO2ddGt5F-HPsZ-_dn_XR9m98_bO6uV_e5WQCknDg2BRbVAsc7kTjYZWNlTdLyailEYwU2IEW95AjclgZMJWRpqOZmKbFGccZ-HXJ3wb8OFJPqXDTUtronP0SFxfR3hXIxonhATfAxBmrULrhOhzfFQU1y1VZNctUkV8FYUI5LP4_5Q92R_b_yYXMErg4AjV_uHQUVjZsMWBfIJGW9-yz_HfuSizM</recordid><startdate>202205</startdate><enddate>202205</enddate><creator>Macbeth, F.</creator><creator>Treasure, T.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202205</creationdate><title>Stereotactic Ablative Radiotherapy for Oligometastatic Disease: Great Enthusiasm but Scant Evidence</title><author>Macbeth, F. ; Treasure, T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-e12f6269420022e10d7fd5be5d19733fd32f053b71201d8c0c9358ceb1c752b23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Lung metastases</topic><topic>Lung Neoplasms - radiotherapy</topic><topic>Lung Neoplasms - surgery</topic><topic>Metastasectomy</topic><topic>Metastases</topic><topic>Prognosis</topic><topic>Prospective Studies</topic><topic>Radiosurgery</topic><topic>Stereotactic radiotherapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Macbeth, F.</creatorcontrib><creatorcontrib>Treasure, T.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical oncology (Royal College of Radiologists (Great Britain))</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Macbeth, F.</au><au>Treasure, T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Stereotactic Ablative Radiotherapy for Oligometastatic Disease: Great Enthusiasm but Scant Evidence</atitle><jtitle>Clinical oncology (Royal College of Radiologists (Great Britain))</jtitle><addtitle>Clin Oncol (R Coll Radiol)</addtitle><date>2022-05</date><risdate>2022</risdate><volume>34</volume><issue>5</issue><spage>313</spage><epage>317</epage><pages>313-317</pages><issn>0936-6555</issn><eissn>1433-2981</eissn><abstract>The prospective study Pulmonary Metastasectomy in Colorectal Cancer (N = 391) showed that expert selection was made on known prognostic features – number of metastases, tumour markers, liver involvement, interval – and patient performance and outcomes replicated follow-up studies. In the nested controlled trial all factors were well balanced and no survival difference remained.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>35232625</pmid><doi>10.1016/j.clon.2022.02.008</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0936-6555 |
ispartof | Clinical oncology (Royal College of Radiologists (Great Britain)), 2022-05, Vol.34 (5), p.313-317 |
issn | 0936-6555 1433-2981 |
language | eng |
recordid | cdi_proquest_miscellaneous_2635239254 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Follow-Up Studies Humans Lung metastases Lung Neoplasms - radiotherapy Lung Neoplasms - surgery Metastasectomy Metastases Prognosis Prospective Studies Radiosurgery Stereotactic radiotherapy |
title | Stereotactic Ablative Radiotherapy for Oligometastatic Disease: Great Enthusiasm but Scant Evidence |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T19%3A26%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Stereotactic%20Ablative%20Radiotherapy%20for%20Oligometastatic%20Disease:%20Great%20Enthusiasm%20but%20Scant%20Evidence&rft.jtitle=Clinical%20oncology%20(Royal%20College%20of%20Radiologists%20(Great%20Britain))&rft.au=Macbeth,%20F.&rft.date=2022-05&rft.volume=34&rft.issue=5&rft.spage=313&rft.epage=317&rft.pages=313-317&rft.issn=0936-6555&rft.eissn=1433-2981&rft_id=info:doi/10.1016/j.clon.2022.02.008&rft_dat=%3Cproquest_cross%3E2635239254%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2635239254&rft_id=info:pmid/35232625&rft_els_id=S0936655522000917&rfr_iscdi=true |